FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

William Morice

Research Profile

Procedures

Anatomy

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
G Bianchi; Angela Dispenzieri; Shaji Kumar; Robert A Kyle; Dirk R Larson; William Morice; Thomas E Witzig; S Vincent Rajkumar
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
Linda N Dao; Angela Dispenzieri; Curtis A Hanson; Paul J Kurtin; William Morice; James D Hoyer
Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients.
Lucy S Hodge; Anne J Novak; Deanna M Grote; Esteban Braggio; Rhett P Ketterling; Michelle K Manske; Tammy L Price-Troska; Steven C Ziesmer; Rafael Fonseca; Thomas E Witzig; William Morice; Morie A Gertz; Stephen M Ansell
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of William Morice (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: G Bianchi; Angela Dispenzieri; Shaji Kumar; Robert A Kyle; Dirk R Larson; William Morice; Thomas E Witzig; S Vincent Rajkumar
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
Leukemia 2013;27(3):680-5.
2011: Linda N Dao; Angela Dispenzieri; Curtis A Hanson; Paul J Kurtin; William Morice; James D Hoyer
Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients.
Blood 2011;117(24):6438-44.
2011: Lucy S Hodge; Anne J Novak; Deanna M Grote; Esteban Braggio; Rhett P Ketterling; Michelle K Manske; Tammy L Price-Troska; Steven C Ziesmer; Rafael Fonseca; Thomas E Witzig; William Morice; Morie A Gertz; Stephen M Ansell
Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1.
Blood 2011;117(19):e190-7.
2010: Dragan Jevremovic; Roxana S Dronca; William Morice; Ellen D McPhail; Paul J Kurtin; Clive S Zent; Curtis A Hanson
CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
Leukemia research 2010;34(9):1235-8.
2010: Benjamin R Kipp; Rhett P Ketterling; Trynda N Oberg; Margot A Cousin; Amy M Plagge; Anne E Wiktor; Johnita M Ihrke; Cecelia H Meyers; William Morice; Kevin C Halling; Amy C Clayton
Comparison of fluorescence in situ hybridization, p57 immunostaining, flow cytometry, and digital image analysis for diagnosing molar and nonmolar products of conception.
American journal of clinical pathology 2010;133(2):196-204.
2010: Roxana S Dronca; Dragan Jevremovic; Curtis A Hanson; Kari G Rabe; Tait D Shanafelt; William Morice; Timothy G Call; Neil E Kay; Charles S Collins; Susan M Schwager; Susan L Slager; Clive S Zent
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
Cytometry. Part B, Clinical cytometry 2010;78 Suppl 1():S35-41.
2009: Tait D Shanafelt; Neil E Kay; Kari G Rabe; Timothy G Call; Clive S Zent; Kami Maddocks; Greg Jenkins; Diane F Jelinek; William Morice; Justin Boysen; Susan M Schwager; Deborah Bowen; Susan L Slager; Curtis A Hanson
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3959-63.
2009: William Morice; Dong Chen; Paul J Kurtin; Curtis A Hanson; Ellen D McPhail
Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(6):807-16.
2009: Tait D Shanafelt; Neil E Kay; Greg Jenkins; Timothy G Call; Clive S Zent; Diane F Jelinek; William Morice; Justin Boysen; Liam Zakko; Susan M Schwager; Susan L Slager; Curtis A Hanson
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Blood 2009;113(18):4188-96.
2008: Anja C Roden; William Morice; Curtis A Hanson
Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase.
Archives of pathology & laboratory medicine 2008;132(11):1774-80.
2008: Tait D Shanafelt; Neil E Kay; Timothy G Call; Clive S Zent; Diane F Jelinek; Betsy LaPlant; William Morice; Curtis A Hanson
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
Leukemia research 2008;32(9):1458-61.
2008: William Morice; Paul J Kurtin; Janice M Hodnefield; Tait D Shanafelt; James D Hoyer; Ellen D Remstein; Curtis A Hanson
Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
Mayo Clinic proceedings. Mayo Clinic 2008;83(7):776-85.
2008: A L Feldman; D X Sun; Mark E Law; Anne J Novak; Ayoma D Attygalle; Erik C Thorland; S R Fink; J A Vrana; B L Caron; William Morice; Ellen D Remstein; Karen L Grogg; Paul J Kurtin; William R Macon; Ahmet Dogan
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.
Leukemia 2008;22(6):1139-43.
2008: Curtis A Hanson; William Morice
The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
American journal of hematology 2008;83(5):347-8.
2008: Prashant Kapoor; Patricia T Greipp; William Morice; S Vincent Rajkumar; Thomas E Witzig; Philip R Greipp
Anti-CD20 monoclonal antibody therapy in multiple myeloma.
British journal of haematology 2008;141(2):135-48.
2008: P T Greipp; P Kapoor; William Morice; T E Witzig; P R Greipp
Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al.
Leukemia 2008;22(1):214-5.
2007: Francois M Cady; William Morice
Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
Clinics in laboratory medicine 2007;27(3):513-32, vi.
2007: William Morice; Curtis A Hanson; S Kumar; L A Frederick; C E Lesnick; P R Greipp
Novel multi-parameter flow cytometry sensitively detects phenotypically distinct plasma cell subsets in plasma cell proliferative disorders.
Leukemia 2007;21(9):2043-6.
2007: Animesh Pardanani; Terra L Lasho; William Morice; R K Pruthi; A Tefferi
JAK2V617F is infrequently associated with arterial stroke in the absence of overt myeloproliferative disorder.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1784-5.
2007: William Morice
The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders.
American journal of clinical pathology 2007;127(6):881-6.
2007: Karen L Grogg; William Morice; William R Macon
Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma.
British journal of haematology 2007;137(5):416-22.
2007: William Morice; Dragan Jevremovic; Curtis A Hanson
The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders.
British journal of haematology 2007;137(3):237-9.
2006: William Morice; William R Macon; A Dogan; Curtis A Hanson; Paul J Kurtin
NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis.
Leukemia 2006;20(5):883-6.
2006: William Morice; Jerry A Katzmann; Mark Pittelkow; Rokea A el-Azhary; Lawrence E Gibson; Curtis A Hanson
A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
American journal of clinical pathology 2006;125(3):364-74.
2005: William Morice; Fausto J Rodriguez; James D Hoyer; Paul J Kurtin
Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(4):495-502.
2005: Grzegorz S Nowakowski; William Morice; Robert L Phyliky; Chin-Yang Li; Ayalew Tefferi
Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia.
British journal of haematology 2005;128(4):490-2.
2005: Grzegorz S Nowakowski; Timothy G Call; William Morice; Paul J Kurtin; Rachel J Cook; Clive S Zent
Clinical significance of monoclonal B cells in cerebrospinal fluid.
Cytometry. Part B, Clinical cytometry 2005;63(1):23-7.
2004: Ahmet Dogan; William Morice
Bone marrow histopathology in peripheral T-cell lymphomas.
British journal of haematology 2004;127(2):140-54.
2004: William Morice; Janice M Hodnefield; Paul J Kurtin; Curtis A Hanson
An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
American journal of clinical pathology 2004;122(1):122-7.
2004: William Morice; Teresa Kimlinger; Jerry A Katzmann; John A Lust; Paul J Heimgartner; Kevin C Halling; Curtis A Hanson
Flow cytometric assessment of TCR-Vbeta expression in the evaluation of peripheral blood involvement by T-cell lymphoproliferative disorders: a comparison with conventional T-cell immunophenotyping and molecular genetic techniques.
American journal of clinical pathology 2004;121(3):373-83.
2003: Michelle A Neben; William Morice; Ayalew Tefferi
Clinical features in T-cell vs. natural killer-cell variants of large granular lymphocyte leukemia.
European journal of haematology 2003;71(4):263-5.
2003: Jason T Lewis; Robyn L Gaffney; Mary B Casey; Michael A Farrell; William Morice; William R Macon
Inflammatory pseudotumor of the spleen associated with a clonal Epstein-Barr virus genome. Case report and review of the literature.
American journal of clinical pathology 2003;120(1):56-61.
2003: Animesh Pardanani; William Morice; James D Hoyer; Ayalew Tefferi
Chronic basophilic leukemia: a distinct clinico-pathologic entity?
European journal of haematology 2003;71(1):18-22.
2003: William Morice; Paul J Kurtin; Paul J Leibson; Ayalew Tefferi; Curtis A Hanson
Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.
British journal of haematology 2003;120(6):1026-36.
2002: William Morice; Paul J Kurtin; Jeffrey L Myers
Expression of cytolytic lymphocyte-associated antigens in pulmonary lymphomatoid granulomatosis.
American journal of clinical pathology 2002;118(3):391-8.
2002: Ravi D Rao; William Morice; Robert L Phyliky
Hemophagocytosis in a patient with chronic lymphocytic leukemia and histoplasmosis.
Mayo Clinic proceedings. Mayo Clinic 2002;77(3):287-90.
2002: William Morice; Paul J Kurtin; Ayalew Tefferi; Curtis A Hanson
Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B.
Blood 2002;99(1):268-74.
2001: William Morice; P J Leibson; Ayalew Tefferi
Natural killer cells and the syndrome of chronic natural killer cell lymphocytosis.
Leukemia & lymphoma 2001;41(3-4):277-84.
2000: David P Steensma; William Morice
Littoral cell angioma associated with portal hypertension and resected colon cancer.
Acta haematologica 2000;104(2-3):131-4.
1998: William Morice; J A Ferreiro
Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry.
Human pathology 1998;29(6):609-12.
1993: William Morice; GJ Wiederrecht; GJ Brunn; John Siekierka; Robert T Abraham
Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
The Journal of biological chemistry 1993;268(30):22737-45.
1993: William Morice; GJ Brunn; GJ Wiederrecht; John Siekierka; Robert T Abraham
Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes.
The Journal of biological chemistry 1993;268(5):3734-8.